The British Society of Echocardiography is delighted to launch our valve disease assessment poster.
Valvular heart disease is common. Prevalence amongst adult populations is estimated at 2.5%, rising to over 10% in those aged older than 75. This equates to over 1.6 million people over the age of 65 currently living with heart valve disease; some estimates suggest that this will double by 2046 and increase further to 3.3 million by 2056. The assessment of valvular function is therefore an extremely common reason for performing echocardiography, routinely leading to surveillance over a number of years.
When valve disease becomes severe, decisions around the timing of intervention combine patients symptoms with multiple echocardiographic parameters of cardiac function to improve patient outcomes and reduce the associated risk of mortality. Consequently, echocardiography is the primary imaging modality for the assessment of disease severity, playing a fundamental role in the surveillance of heart valve disease and in determining the appropriate time for valvular intervention.
The new valve disease assessment poster centralises the guidance from the recent BSE guidelines and will provide departments and echocardiographers with a single reference point when diagnosing valve disease severity. When considered alongside the BSE posters for triaging echocardiography requests and appropriate monitoring intervals, this poster is an invaluable resource for the diagnosis, surveillance and management of patients with valve disease.
Orders for the physical version of this poster have closed. Download the print ready version of the poster by clicking the button below.
Copies of this poster are also available from the poster sponsors, GE Healthcare and Philips Healthcare.